AMGN
Amgen Inc.
Stock
$407.27−14.24 (−3.38%)Close Oct 1, 2026
Income statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38.1B | $36.8B | $33.4B | $28.2B | $26.3B | $26.0B | $25.4B | $23.4B | $23.7B | $22.8B | $23.0B | $21.7B | $20.1B | $18.7B | $17.3B | $15.6B | $15.1B | $14.6B | $15.0B | $14.8B |
| Cost of revenue | $11.6B | $12.0B | $12.9B | $8.5B | $6.4B | $6.5B | $6.2B | $4.4B | $4.1B | $4.1B | $4.2B | $4.2B | $4.4B | $3.3B | $3.2B | $2.7B | — | — | — | — |
| Gross profit | $26.5B | $24.7B | $20.6B | $19.7B | $19.9B | $19.5B | $19.3B | $19.0B | $19.6B | $18.8B | $18.8B | $17.4B | $15.6B | $15.3B | $14.1B | $12.9B | — | — | — | — |
| R&D | $7.6B | $7.3B | $6.0B | $4.8B | $4.4B | $4.8B | $4.2B | $4.1B | $3.7B | $3.6B | $3.8B | $4.1B | $4.3B | $4.1B | $3.4B | $3.2B | $2.9B | $2.9B | $3.0B | $3.3B |
| SG&A | $7.0B | $7.1B | $7.1B | $6.2B | $5.4B | $5.4B | $5.7B | $5.2B | $5.3B | $4.9B | $5.1B | $4.8B | $4.7B | $5.2B | $4.8B | $4.5B | $4.0B | $3.8B | $3.8B | $3.4B |
| Other operating expenses | $408M | $1.3B | $248M | $879M | $503M | $1.7B | $189M | $66M | $314M | $375M | $133M | $49M | $454M | $196M | $295M | $896M | — | — | — | — |
| Operating income | $11.4B | $9.1B | $7.3B | $7.9B | $9.6B | $7.6B | $9.1B | $9.7B | $10.3B | $10.0B | $9.8B | $8.5B | $6.2B | $5.9B | $5.6B | $4.3B | $5.5B | $5.5B | $5.2B | $4.0B |
| Non-operating income | — | −$104M | −$2.6B | −$42M | −$2.2B | −$938M | −$1.0B | −$536M | −$718M | −$376M | −$631M | −$492M | −$606M | −$602M | −$568M | −$162M | −$228M | −$302M | −$199M | −$187M |
| Pretax income | — | $9.0B | $4.6B | $7.9B | $7.3B | $6.7B | $8.1B | $9.1B | $9.5B | $9.6B | $9.2B | $8.0B | $5.6B | $5.3B | $5.0B | $4.2B | $5.3B | $5.2B | $5.0B | $3.8B |
| Taxes | — | $1.3B | $519M | $1.1B | $794M | $808M | $869M | $1.3B | $1.2B | $7.6B | $1.4B | $1.0B | $427M | $184M | $664M | $467M | $690M | $599M | $963M | $715M |
| Net income | $8.7B | $7.7B | $4.1B | $6.7B | $6.6B | $5.9B | $7.3B | $7.8B | $8.4B | $2.0B | $7.7B | $6.9B | $5.2B | $5.1B | $4.3B | $3.7B | $4.6B | $4.6B | $4.1B | $3.1B |
| Diluted EPS | $16.09 | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 | $12.31 | $12.88 | $12.62 | $2.69 | $10.24 | $9.06 | $6.70 | $6.64 | $5.52 | $4.04 | $4.79 | $4.51 | $3.77 | $2.74 |
| Diluted shares | — | 542.0M | 541.0M | 538.0M | 541.0M | 573.0M | 590.0M | 609.0M | 665.0M | 735.0M | 754.0M | 766.0M | 770.0M | 765.0M | 787.0M | 912.0M | 965.0M | 1.02B | 1.08B | 1.12B |
| Revenue growth | — | +10.0% | +18.6% | +7.1% | +1.3% | +2.2% | +8.8% | −1.6% | +3.9% | −0.6% | +6.1% | +8.0% | +7.4% | +8.2% | +10.8% | +3.5% | +2.8% | −2.4% | +1.6% | — |
| Gross margin | 69.5% | 67.2% | 61.5% | 70.0% | 75.7% | 75.2% | 75.8% | 81.4% | 82.7% | 82.2% | 81.9% | 80.5% | 78.0% | 82.1% | 81.5% | 82.6% | — | — | — | — |
| Operating margin | 30.0% | 24.7% | 21.7% | 28.0% | 36.3% | 29.4% | 35.9% | 41.4% | 43.2% | 43.6% | 42.6% | 39.1% | 30.9% | 31.4% | 32.3% | 27.7% | 36.8% | 37.6% | 34.8% | 26.9% |
| Net margin | 23.0% | 21.0% | 12.2% | 23.8% | 24.9% | 22.7% | 28.6% | 33.6% | 35.3% | 8.7% | 33.6% | 32.0% | 25.7% | 27.2% | 25.2% | 23.6% | 30.7% | 31.5% | 27.0% | 20.8% |
Cost of revenue, other operating expenses, non-operating income and taxes are the differences between the lines reported around them.